| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0032 | 1 |